| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma
|
Shay, Rebecca
|
|
|
19 |
4 |
p. 370-370.e7
|
artikel
|
| 2 |
Apparent Diffusion Coefficient Value can Predict Poor Bacillus Calmette–Guérin Responders in T1HG/NMIBC: Prospective Cohort Study
|
Abd Elwahab, Khaled M
|
|
|
19 |
4 |
p. e248-e254
|
artikel
|
| 3 |
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder
|
Challapalli, Amarnath
|
|
|
19 |
4 |
p. 325-332
|
artikel
|
| 4 |
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib
|
Rossini, Elisa
|
|
|
19 |
4 |
p. 316-324
|
artikel
|
| 5 |
Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study
|
Wells, J. Connor
|
|
|
19 |
4 |
p. 354-361
|
artikel
|
| 6 |
Contemporary National Trends and Variations of Pelvic Lymph Node Dissection in Patients Undergoing Robot-Assisted Radical Prostatectomy
|
Xia, Leilei
|
|
|
19 |
4 |
p. 309-315
|
artikel
|
| 7 |
Cutoff Values of Prostate Imaging Reporting and Data System Version 2.1 Score in Men With Prostate-specific Antigen Level 4 to 10 ng/mL: Importance of Lesion Location
|
Chen, Yuanchong
|
|
|
19 |
4 |
p. 288-295
|
artikel
|
| 8 |
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study
|
Culine, Stéphane
|
|
|
19 |
4 |
p. e216-e222
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
19 |
4 |
p. A1
|
artikel
|
| 10 |
Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis
|
Chi, Chenfei
|
|
|
19 |
4 |
p. e223-e234
|
artikel
|
| 11 |
Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience
|
Sterling, Joshua
|
|
|
19 |
4 |
p. 275-279
|
artikel
|
| 12 |
Molecular Imaging of Neuroendocrine Differentiation of Prostate Cancer: A Case Series
|
Iravani, Amir
|
|
|
19 |
4 |
p. e200-e205
|
artikel
|
| 13 |
Overall Survival of Biopsy-confirmed T1B and T2A Kidney Cancers Managed With Observation: Prognostic Value of Tumor Histology
|
Michael, Jamie
|
|
|
19 |
4 |
p. 280-287
|
artikel
|
| 14 |
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy
|
Tward, Jonathan D.
|
|
|
19 |
4 |
p. 296-304.e3
|
artikel
|
| 15 |
Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)
|
Patel, Sunil H.
|
|
|
19 |
4 |
p. e206-e215
|
artikel
|
| 16 |
Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma
|
Santos, Victor Espinheira
|
|
|
19 |
4 |
p. 339-345
|
artikel
|
| 17 |
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET
|
Gravis, Gwenaelle
|
|
|
19 |
4 |
p. 346-353
|
artikel
|
| 18 |
PSMA Theranostics: A “Must Have” in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature
|
Cytawa, Wojciech
|
|
|
19 |
4 |
p. e235-e247
|
artikel
|
| 19 |
Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis
|
Deuker, Marina
|
|
|
19 |
4 |
p. e264-e271
|
artikel
|
| 20 |
Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER Registries
|
Wenzel, Mike
|
|
|
19 |
4 |
p. e255-e263
|
artikel
|
| 21 |
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database
|
Xu, Karen M.
|
|
|
19 |
4 |
p. e193-e199
|
artikel
|
| 22 |
Table of contents
|
|
|
|
19 |
4 |
p. A2-A6
|
artikel
|
| 23 |
TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
|
Kruslin, Bozo
|
|
|
19 |
4 |
p. 333-338
|
artikel
|
| 24 |
The Stage at Presentation and Oncologic Outcomes for Agent Orange Exposed and Non-Exposed United States Veterans Diagnosed With Prostate Cancer
|
Tward, Alexander E.
|
|
|
19 |
4 |
p. 369-369.e7
|
artikel
|
| 25 |
The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada
|
Wissing, Michel D.
|
|
|
19 |
4 |
p. 371-371.e9
|
artikel
|
| 26 |
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
|
Royce, Trevor J.
|
|
|
19 |
4 |
p. 362-368
|
artikel
|
| 27 |
Which Prostate Biopsy in Men Enrolled in Active Surveillance? Experience in 110 Men Submitted to Scheduled Three-Years Transperineal Saturation Biopsy Combined With Fusion Targeted Cores
|
Pepe, Pietro
|
|
|
19 |
4 |
p. 305-308
|
artikel
|
Tijdschrift beschrijving